Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
Letong Cai, Yuchen Li, Jiaxiong Tan, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 119
Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal “unity of ecology and evolution” pathological ecosystem
Weiren Luo
Theranostics (2023) Vol. 13, Iss. 5, pp. 1607-1631
Open Access | Times Cited: 116
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 103
Spatial transcriptomics: Technologies, applications and experimental considerations
Ye Wang, Bin Liu, Gexin Zhao, et al.
Genomics (2023) Vol. 115, Iss. 5, pp. 110671-110671
Open Access | Times Cited: 76
Nanozyme-mediated biocatalysis as a mitochondrial oxidative stress amplifier for tumor nanocatalytic immunotherapy
Junya Lu, Luming Song, Shuaipeng Feng, et al.
Chemical Engineering Journal (2023) Vol. 481, pp. 148270-148270
Closed Access | Times Cited: 76
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 65
Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
Mengke Niu, Ming Yi, Yuze Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 46
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Versatile function of NF-ĸB in inflammation and cancer
Qiang Ma, Shuai Hao, Weilong Hong, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Dressing Bacteria With a Hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and Antiviral Immunity
Ying Liu, Mengmeng Zhang, Xinyue Wang, et al.
Advanced Materials (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 52
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis
Sun-Young Jung, You Jeong Heo, Sehhoon Park
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006454-e006454
Open Access | Times Cited: 40
A Noninvasive Approach to Evaluate Tumor Immune Microenvironment and Predict Outcomes in Hepatocellular Carcinoma
Jianmin Wu, Wanmin Liu, Xinyao Qiu, et al.
Phenomics (2023) Vol. 3, Iss. 6, pp. 549-564
Open Access | Times Cited: 29
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
Grayson Herrgott, James M. Snyder, Ruicong She, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target
Marsha Pellegrino, Valerio Secli, Silvia D’Amico, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model
Kun Zheng, Youlong Hai, Hongqi Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Targeted delivery of nano-radiosensitizers for tumor radiotherapy
Shuzhi Shi, Haibo Zhong, Yong Zhang, et al.
Coordination Chemistry Reviews (2024) Vol. 518, pp. 216101-216101
Closed Access | Times Cited: 8
Chemodynamic/Photothermal Synergistic Cancer Immunotherapy Based on Yeast Microcapsule-Derived Au/Pt Nanoparticles
Runzan Zhang, Xianya Qin, Junyu Lu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 20, pp. 24134-24148
Closed Access | Times Cited: 20
Novel immune checkpoint targets: A promising therapy for cancer treatments
Mohsina Patwekar, Nouroz Sehar, Faheem Patwekar, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111186-111186
Closed Access | Times Cited: 20
Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 18
Immunometabolic reprogramming, another cancer hallmark
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
TME-targeted approaches of brain metastases and its clinical therapeutic evidence
Ibrar Muhammad Khan, Safir Ullah Khan, Hari Siva Sai Sala, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
Lihaoyun Huang, Haitao Li, Cangang Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 6
Revolutionizing cancer treatment: nanotechnology-enabled photodynamic therapy and immunotherapy with advanced photosensitizers
Jiedong Jia, Xue Wu, Gongwei Long, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms
Jixuan Zheng, Jinting Jiang, Yicheng Pu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top